4//SEC Filing
GLS GP LTD 4
Accession 0001209191-04-020331
CIK 0001062216other
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 4:55 PM ET
Size
19.1 KB
Accession
0001209191-04-020331
Insider Transaction Report
Form 4
Transactions
- Conversion
Series B Convertible Preferred Stock
2004-04-08−357,143→ 0 total(indirect: See Footnote)→ Common Stock (119,047 underlying) - Conversion
Common Stock
2004-04-08+487,598→ 487,598 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2004-04-08−600,000→ 0 total(indirect: See Footnote)→ Common Stock (213,512 underlying) - Conversion
Series D Convertible Preferred Stock
2004-04-08−465,117→ 0 total(indirect: See Footnote)→ Common Stock (155,039 underlying)
GLS GP LTD
Other
Transactions
- Conversion
Series B Convertible Preferred Stock
2004-04-08−357,143→ 0 total(indirect: See Footnote)→ Common Stock (119,047 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−600,000→ 0 total(indirect: See Footnote)→ Common Stock (213,512 underlying) - Conversion
Common Stock
2004-04-08+487,598→ 487,598 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−465,117→ 0 total(indirect: See Footnote)→ Common Stock (155,039 underlying)
Transactions
- Conversion
Common Stock
2004-04-08+487,598→ 487,598 total(indirect: See Footnote) - Conversion
Series D Convertible Preferred Stock
2004-04-08−465,117→ 0 total(indirect: See Footnote)→ Common Stock (155,039 underlying) - Conversion
Series B Convertible Preferred Stock
2004-04-08−357,143→ 0 total(indirect: See Footnote)→ Common Stock (119,047 underlying) - Conversion
Series C Convertible Preferred Stock
2004-04-08−600,000→ 0 total(indirect: See Footnote)→ Common Stock (213,512 underlying)
Footnotes (5)
- [F1]The shares of Convertible Preferred Stock reported consist of shares held of record by each of the entities listed below. GLS (GP) Limited is the general partner of Global Life Science Limited Partnership, who is in turn the general partner of GLS LP Investment I Limited. Each of the Filing Persons disclaims beneficial ownership of the shares except to the extent of his or its pecuniary interest therein.
- [F2]Each share of Series B and Series D Convertible Preferred Stock converted into .3333 shares of Common Stock.
- [F3]These securities automatically converted into Common Stock upon the closing of the Issuer's initial public offering.
- [F4]These securities do not have an expiration date.
- [F5]Each share of Series C Convertible Preferred Stock converted into .3559 shares of Common Stock.
Issuer
MEMORY PHARMACEUTICALS CORP
CIK 0001062216
Entity typeother
Related Parties
1- filerCIK 0001284387
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 4:55 PM ET
- Size
- 19.1 KB